Amakuru y'ibicuruzwa
Izina:Cabazitaxel
Numero ya CAS:183133-96-2
Imiti yimiti:C45H57NO14
Ibisobanuro:99%
Ibara:ifu yera cyangwa itari yera
Inkomoko:Igice cya kabiri hamwe na 10-DAB
Ubwoko:APIs
Imikorere
Igeragezwa rya Clinical ryerekanye ko cabazitaxel ishobora kugabanya ibibyimba, kugabanya imikurire cyangwa gukwirakwiza ibibyimba, no kugabanya ibimenyetso bya kanseri ya prostate.
Ahantu ho gusaba
Inganda zimiti
Imbaraga za Hande
Hande afite itsinda R&D imyaka myinshi.Iri tsinda ryasabye ibintu byinshi byavumbuwe, kandi inzira ntisanzwe kuva muri laboratoire kugeza ku bicuruzwa rusange.Uruganda rwa GMP rwiyubakiye rwatsinze isuzuma ry’amabwiriza ya Amerika FDA, EU EDQM, Ubushinwa GMP, Ubuyapani PMDA, Ositaraliya TGA, Koreya y'Epfo, Ubuhinde, Ubushinwa Tayiwani, Turukiya, Uburusiya, SGS, Dun & Bradstreet n'andi mabwiriza.Muri icyo gihe, isosiyete ifite itsinda ry’ubushakashatsi n’iterambere, kandi yagiye ikurikirana patenti nyinshi.Icyumba cyo kugerageza QC, menya neza igeragezwa ryibicuruzwa.
Ba umutanga mwiza wibikoresho fatizo ninganda zifite ubunyangamugayo!
Murakaza neza kundeba mwohereza imeri kurimarketing@handebio.com